An autoantibody targeting glycated IgG is associated with elevated serum immune complexes in rheumatoid arthritis (RA)

Clinical and Experimental Immunology

Volumn 120, Issue 1, 2000, Pages 188-193

  Tai, A W H ^a   Newkirk, M M ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Advanced glycation end products; Autoantibody; Diabetes; Rheumatoid arthritis; Rheumatoid factor

Indexed keywords

AUTOANTIBODY; GLYCOSYLATED ALBUMIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAIN;

AMERICAN INDIAN; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GLYCATION; HUMAN; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN PURIFICATION; RHEUMATOID ARTHRITIS;

EID: 0034108033     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01188.x     Document Type: Article

References (28)

1. Robbins DL, Feigal Dw Jr, Leek JC. Relationship of serum IgG rheumatoid factor and disease activity in rheumatoid arthritis. J Rheumatol 1986; 13:259-62.
2. Eberhardt KB, Truedsson L, Petersson H et al. Disease activity and joint damage progression in early rheumatoid arthritis: relationship to IgG, IgA and IgM rheumatoid factors. Ann Rheum Dis 1990; 49:906-9.
3. van Schaardenburg D, Hazes JMW, de Boer A et al. Outcome of rheumatoid arthritis in relation to age and rheumatoid factor at diagnosis. J Rheumatol 1993; 20:45-52.
4. Wagner U, Kaltenhauser S, Sauer H et al. HLA markers and prediction of clinical course and outcome in rheumatoid arthritis. Arthritis Rheum 1997; 40:341-51.
5. Weyand CM, Hicok KC, Conn DL, Goronzy JJ. The influence of HLA-DRβ1 genes on disease severity in rheumatoid arthritis. Ann Intern Med 1992; 117:801-6.
6. Hammer J, Gallazzi F, Bono E et al. Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J Exp Med 1995; 181:1847-55.
7. Rodriguez-Garcia J, Requena JR, Rodriguez-Segade R. Increased concentrations of serum pentosidine in rheumatoid arthritis. Clin Chem 1998; 44:250-5.
8. Takahashi M, Suzuki M, Kushida K, Miyamoto S, Inoue T. Relationship between pentosidine levels in serum and urine and activity in rheumatoid arthritis. Br J Rheumatol 1997; 36:637-42.
9. Bucala R, Cerami A. Advanced glycosylation: chemistry, biology, and implications for diabetes and aging. Adv Pharmacol 1992; 23:1-34.
10. Vlassara H. Recent progress in advanced glycation end products and diabetic complications. Diabetes 1997; 46 (Suppl. 2):S19-25.
11. Ligier S, Fortin PR, Newkirk MM. A new antibody in rheumatoid arthritis targeting glycated IgG: IgM anti-IgG-AGE. Br J Rheumatol 1998; 37:1307-14.
12. Newkirk MM, Lepage K, Niwa T, Rubin L. Advanced glycation endproducts (AGE) on IgG, a target for circulating antibodies in North American Indians with rheumatoid arthritis (RA). Cell Mol Biol 1998; 44:1129-38.
13. Lucey M, Newkirk MM, Neville C et al. Association between the IgM response to IgG damaged by glyoxidation and disease activity in rheumatoid arthritis. J Rheumatol 2000; 27.
14. Del Puente A, Knowler WC, Pettitt DJ, Bennett PH. High incidence and prevalence of rheumatoid arthritis in Pima Indians. Am J Epidemiol 1989; 129:1170-8.
15. Jacobsson LTH, Knowler WC, Pillemer S et al. Rheumatoid arthritis and mortality. A longitudinal study in Pima Indians. Arthritis Rheum 1993; 36:1045-53.
16. Arnett FC, Edworthy SJ, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24.
17. Zubler RH, Perrin LH, Creighton WD et al. Use of polyethylene glycol (PEG) to concentrate immune complexes from serum or plasma samples. Ann Rheum Dis 1977; 36:23-25.
18. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-5.
19. Wray W, Boulikas T, Wray VP, Hancock R. Silver staining of proteins in polyacrylamide gels. Anal Biochem 1981; 118:197-203.
20. Svenson KLG, Pollare T, Lithell H, Hallgren R. Impaired glucose handling in active rheumatoid arthritis: relationship to peripheral insulin resistance. Metabolism 1988; 37:125-30.
21. Sakul H, Pratley R, Cardon L et al. Familiality of physical and metabolic characteristics that predict the development of non-insulin-dependent diabetes mellitus in Pima Indians. Am J Hum Genet 1997; 60:651-6.
22. Lunec J, Halloran SP, White AG, Dormandy TL. Free-radical oxidation (peroxidation) products in serum and synovial fluid in rheumatoid arthritis. J Rheumatol 1981; 8:233-45.
23. Kaur H, Edmonds SE, Blake DR, Halliwell B. Hydroxyl radical generation by rheumatoid blood and knee joint synovial fluid. Ann Rheum Dis 1996; 55:915-20.
24. Hirsch R, Lin JP, Scott WW et al. Rheumatoid arthritis in the Pima Indians. Arthritis Rheum 1998; 41:1464-9.
25. Engel A, Roberts J, Burch TA. Rheumatoid arthritis in adults. United States 1960-62. Public Health Service Publication, No 1000, Series 11, no. 17, 1966.
26. Jacono J, Jacono B, Cano P, Segami M, Rubin L. An epidemiological study of rheumatoid arthritis in a northern Ontario clinical practice: the role of ethnicity. J Adv Nursing 1996; 24:31-35.
27. Kabat EA, Wu TT, Perry HM et al. Sequences of proteins of immunological interest, 5th edn. NIH Publication 1991; 91-3242.
28. Barlow AK, He X, Janeway C. Exogenously provided peptides of a self-antigen can be processed into forms that are recognized by self-T cells. J Exp Med 1998; 187:1403-15.